Markets:

Overview

News

Currencies

International

Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

4.360 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 29, 2023

Via Benzinga

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

May 26, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Ulta Beauty, Tilray Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 26, 2023

U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Analyst Ratings for Iovance Biotherapeutics ↗

May 10, 2023

Via Benzinga

Recap: Iovance Biotherapeutics Q1 Earnings ↗

May 09, 2023

Via Benzinga

Wall Street Thinks These 2 Nasdaq Stocks Could Go Parabolic Soon ↗

April 20, 2023

These two biotech stocks might be significantly undervalued.

Via The Motley Fool

Analyst Expectations for Iovance Biotherapeutics's Future ↗

March 27, 2023

Via Benzinga

Expert Ratings for Iovance Biotherapeutics ↗

March 06, 2023

Via Benzinga

The Latest Analyst Ratings for Iovance Biotherapeutics ↗

January 24, 2023

Via Benzinga

Iovance Biotherapeutics Reports First Quarter 2023 Financial Results and Corporate Updates

May 09, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host First Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, May 9, 2023

May 02, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Shares of Iovance Biotherapeutics Jumped Monday ↗

May 01, 2023

The stock bounced back big from its 52-week low last week.

Via The Motley Fool

Iovance Biotherapeutics to Present at Upcoming Conferences

April 24, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

What 6 Analyst Ratings Have To Say About Iovance Biotherapeutics ↗

December 09, 2022

Via Benzinga

Why Shares of Iovance Biotherapeutics Jumped Monday ↗

March 27, 2023

The company filed a Biologics License Application to the FDA for its lead therapy.

Via The Motley Fool

Why Iovance Biotherapeutics Shares Are Trading Higher Today ↗

March 27, 2023

Iovance Biotherapeutics (NASDAQ: IOVA) shares are trading higher on Monday after the company completed its Biologics License Application submission for lifileucel.

Via Benzinga

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 27, 2023

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

Via Benzinga

Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

March 27, 2023

Gainers Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday.

Via Benzinga

First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

March 27, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma

March 24, 2023

First TIL Therapy BLA Submission to U.S. Food and Drug Administration

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Present at Upcoming Conferences

March 01, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

February 28, 2023

First Biologics License Application (BLA) Submission on Track to Complete in 1Q23

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, February 28, 2023

February 21, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023 ↗

January 27, 2023

Via Benzinga

American Express, Visa And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

January 27, 2023

U.S. stock futures traded slightly lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Why Iovance Biotherapeutics Stock Soared 12% Higher Today ↗

January 23, 2023

A business, clinical, and regulatory update lifted the spirits of investors.

Via The Motley Fool

Iovance Biotherapeutics Acquires Clinigen's IL-2 Product For Upfront £166.7M ↗

January 23, 2023

Via Benzinga

Iovance Biotherapeutics Provides Corporate, Clinical, and Regulatory Updates

January 23, 2023

From Iovance Biotherapeutics, Inc.

Via GlobeNewswire

Why Is Iovance Biotherapeutics (IOVA) Stock Soaring 20% Today? ↗

December 05, 2022

Although Iovance Biotherapeutics cuts a speculative figure, IOVA stock managed to skyrocket on Monday off insider buying.

Via InvestorPlace

Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session ↗

December 05, 2022

Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share.

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.